Andrew L. Price
Known title: Chief Accounting OfficerCIK: 0001475399
Associated companies
Transaction History
| EHC | ▼ Sell | Open Market | 5,211 | $630K | 8/31/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 307 | $33K | 2/28/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 404 | $43K | 2/23/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 228 | $24K | 2/20/2026 | View on chart |
| EHC | ▲ Buy | Grant | 1,560 | $0 | 2/19/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 3,692 | $396K | 2/19/2026 | View on chart |
| EHC | ▲ Buy | Grant | 8,178 | $0 | 2/18/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 304 | $30K | 2/28/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 410 | $41K | 2/25/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 401 | $39K | 2/24/2025 | View on chart |
| EHC | ▲ Buy | Grant | 1,538 | $0 | 2/20/2025 | View on chart |
| EHC | ▼ Sell | Open Market | 5,042 | $496K | 2/13/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 2,446 | $226K | 1/1/2025 | View on chart |
| EHC | ▲ Buy | Grant | 2,069 | $0 | 2/28/2024 | View on chart |
| EHC | ▲ Buy | Grant | 5,329 | $0 | 2/28/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 410 | $31K | 2/25/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 320 | $24K | 2/24/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 400 | $30K | 2/23/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 2,062 | $138K | 1/2/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 410 | $25K | 2/27/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 320 | $19K | 2/24/2023 | View on chart |
| EHC | ▲ Buy | Grant | 2,726 | $0 | 2/23/2023 | View on chart |
| EHC | ▲ Buy | Grant | 4,388 | $0 | 2/23/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 298 | $19K | 2/21/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 1,344 | $80K | 1/3/2023 | View on chart |
| EHC | ▲ Buy | Grant | 2,318 | $0 | 2/25/2022 | View on chart |
| EHC | ▲ Buy | Grant | 2,264 | $0 | 2/25/2022 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 265 | $17K | 2/24/2022 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 525 | $35K | 2/22/2022 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 1,031 | $67K | 1/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.